Literature DB >> 12521653

Oral contraceptives: a risk factor for uncontrolled blood pressure among hypertensive women.

Jaqueline Neves Lubianca1, Carlo Sasso Faccin, Flávio Danni Fuchs.   

Abstract

The objective of the study was to assess the association between systolic and diastolic blood pressure (SBP and DBP) and the use of oral contraceptives (OC) in hypertensive women. In a prospective cross-sectional study, we evaluated 171 women who were referred to the Hypertension Outpatient Clinic of Hospital de Clínicas de Porto Alegre; 66 current users of OC, 26 users of other contraceptive methods and 79 women who were not using contraception. The average of six blood pressure readings was used to establish the usual blood pressure of the participants. Current OC users were compared with users of other methods and with patients not using contraception. Main outcome measures were SBP and DBP among the different groups, and prevalence of uncontrolled hypertension (SBP >or= 140 mmHg and DBP >or= 90 mmHg). DBP was higher in OC users (100.2 +/- 15.9 mmHg) than in patients using other contraceptive methods (93.4 +/- 14.7 mmHg) and not using contraceptives (93.3 +/- 14.4 mmHg, p = 0.016). Women using OC for more than 8 years presented higher age-adjusted blood pressure levels than women using OC for shorter periods. Patients using OC had poor blood pressure control (p for trend = 0.046) and a higher proportion of them presented moderate-severe hypertension. These results were independent of antihypertensive drug use. In a logistic regression model, we found that current OC use was independently and significantly associated with prevalence of uncontrolled hypertension. It is concluded that hypertensive women using OC present a significant increase in DBP and poor blood pressure control, independent of age, weight and antihypertensive drug treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12521653     DOI: 10.1016/s0010-7824(02)00429-8

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  13 in total

1.  The impact of hormonal contraceptives on blood pressure, urinary albumin excretion and glomerular filtration rate.

Authors:  Jarir Atthobari; Ron T Gansevoort; Sipke T Visser; Paul E de Jong; Lolkje T W de Jong-van den Berg
Journal:  Br J Clin Pharmacol       Date:  2007-02       Impact factor: 4.335

Review 2.  Ischemic heart disease in women: a focus on risk factors.

Authors:  Puja K Mehta; Janet Wei; Nanette K Wenger
Journal:  Trends Cardiovasc Med       Date:  2014-10-16       Impact factor: 6.677

Review 3.  Non-interventional management of resistant hypertension.

Authors:  Michael Doumas; Costas Tsioufis; Charles Faselis; Antonios Lazaridis; Haris Grassos; Vasilios Papademetriou
Journal:  World J Cardiol       Date:  2014-10-26

Review 4.  Estrogen and hypertension.

Authors:  Muhammad S Ashraf; Wanpen Vongpatanasin
Journal:  Curr Hypertens Rep       Date:  2006-10       Impact factor: 5.369

5.  What Is or What Is Not a Risk Factor for Arterial Hypertension? Not Hamlet, but Medical Students Answer That Question.

Authors:  Tomasz Sobierajski; Stanisław Surma; Monika Romańczyk; Krzysztof Łabuzek; Krzysztof J Filipiak; Suzanne Oparil
Journal:  Int J Environ Res Public Health       Date:  2022-07-05       Impact factor: 4.614

6.  Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.

Authors:  Robert M Carey; David A Calhoun; George L Bakris; Robert D Brook; Stacie L Daugherty; Cheryl R Dennison-Himmelfarb; Brent M Egan; John M Flack; Samuel S Gidding; Eric Judd; Daniel T Lackland; Cheryl L Laffer; Christopher Newton-Cheh; Steven M Smith; Sandra J Taler; Stephen C Textor; Tanya N Turan; William B White
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

Review 7.  Resistant Hypertension Updated Guidelines.

Authors:  Irene Chernova; Namrata Krishnan
Journal:  Curr Cardiol Rep       Date:  2019-08-30       Impact factor: 2.931

8.  Common secondary causes of resistant hypertension and rational for treatment.

Authors:  Charles Faselis; Michael Doumas; Vasilios Papademetriou
Journal:  Int J Hypertens       Date:  2011-03-02       Impact factor: 2.420

9.  Associations between oral contraceptive use and risks of hypertension and prehypertension in a cross-sectional study of Korean women.

Authors:  Hyejin Park; Kisok Kim
Journal:  BMC Womens Health       Date:  2013-10-21       Impact factor: 2.809

10.  Effect of hormonal contraceptives on lipid profile and the risk indices for cardiovascular disease in a Ghanaian community.

Authors:  George A Asare; Sheila Santa; Robert A Ngala; Bernice Asiedu; Daniel Afriyie; Albert Gb Amoah
Journal:  Int J Womens Health       Date:  2014-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.